Table_1_Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy.pdf
收藏NIAID Data Ecosystem2026-03-13 收录
数据链接：
官方服务：
资源简介：
The full text of this article can be freely accessed on the publisher's website.
创建时间：
2022-06-23
